Disease impact number and population impact number: population perspectives to measures of risk and benefit Commentary: DINS, PINS, and things---clinical and population perspectives on treatment effects
- 14 October 2000
- Vol. 321 (7266), 950-953
- https://doi.org/10.1136/bmj.321.7266.950
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Predicted impact of intravenous thrombolysis on prognosis of general population of stroke patients: simulation modelBMJ, 1999
- Guidelines and killer B's.1999
- Numbers needed to treat derived from meta-analyses---sometimes informative, usually misleadingBMJ, 1999
- Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised studyThe Lancet, 1999
- Secondary Prevention for Ischemic Heart DiseaseArchives of Internal Medicine, 1997
- The number needed to treat: a clinically useful measure of treatment effectBMJ, 1995
- Science of urinary incontinenceThe Lancet, 1994
- Who benefits from medical interventions?BMJ, 1994
- A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project--1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage.Journal of Neurology, Neurosurgery & Psychiatry, 1990
- An Assessment of Clinically Useful Measures of the Consequences of TreatmentNew England Journal of Medicine, 1988